乙肝治疗的新概念（New concept of hepatitis B treatment）.docVIP

下载本文档

7
0
约3.16万字
约 21页
2017-09-06 发布于河南
举报
版权申诉

乙肝治疗的新概念（New concept of hepatitis B treatment）.doc

1、本文档共21页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

乙肝治疗的新概念（New concept of hepatitis B treatment）

乙肝治疗的新概念（New concept of hepatitis B treatment） Held in November this year, the annual meeting of the American Association for the study of liver disease, hepatitis B experts from around the world presented a new concept in the treatment of chronic hepatitis B, hepatitis B is no longer an incurable disease. The yuan Red (a pseudonym) is a Beijing girl, a routine medical examination at the age of 5, found himself anti-O-positive (commonly known as the second hepatomegaly Sanyang), because of fear of being discriminated against, has been holding out. Gao Yi (2000), the family is afraid to affect Xiao Hong college entrance examination, in a hospital began treatment for her. At the time of liver function normal red, not half a dozen common interferon, then to lamivudine, hepatitis B virus DNA load in the blood after six months (concentration) from 108 copies / ml decreased to 103 copies / ml, but there is no negative E antigen. Check in after 14 months, and DNA jumps back to 106 copies / ml.. So her family found Capital Medical University Beijing Youan Hospital doctor Chen moon for her treatment, the test for the YMDD mutation positive red, she is the body of the hepatitis B virus has been resistant to lamivudine. There was a few months before the college entrance exam, in order to control the disease, Chen Xinyue suggested that Xiao continue to take lamivudine until the end of the college entrance examination to stop the observation and seek the appropriate treatment opportunities. In 2002, Xiao Hong was admitted to a foreign university to check the liver function every 3 months. After a year and a half of elevated transaminase levels (299U/L), Chen Xinyue said the time had come for antiviral treatment. Considering that Xiao Hong had been treated with normal interferon and lamivudine, none of which was effective, Chen Xinyue suggested that she use a combination of long-acting interferon and lamivudine. Interferon needs to be frozen, so Xiao Hong spends 50 yuan a month r